Rule lifecycle · DOCKET:DEA-1337
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
Department of Justice, Drug Enforcement Administration — observed across 3 documents over 482 days. Use the source documents below before deciding whether this affects your business.
In plain English
The DEA now classifies two synthetic opioids (N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene) as Schedule I drugs, making them completely illegal to produce, sell, or own. If you work in healthcare, pharmacies, or research, check your supplies right away to make sure you don't have these drugs and update your compliance rules.
First seen
Sep 17, 2024
Last seen
Jan 12, 2026
Latest stage
Rule
PRORULE → RULE
482d
Effective on
Wednesday, February 11, 2026
Stage timeline
Proposed·Sep 17, 2024
Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
effective Sep 17, 2024#2024-21058
Final·Aug 15, 2025
N N Schedules of Controlled Substances: Temporary Placement of-pyrrolidino metonitazene and-pyrrolidino protonitazene in Schedule I
effective Aug 15, 2025#2025-15566
Final·Jan 12, 2026
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
effective Feb 11, 2026#2026-00362